Team:Washington/DataTable
From 2010.igem.org
(Difference between revisions)
(4 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
+ | __NOTOC__ | ||
+ | {{Template:Team:Washington/Templates/Header}} | ||
+ | <html> | ||
+ | <script type="text/javascript"> | ||
+ | $(function() { | ||
+ | var mainimg = document.getElementById("mainimg"); | ||
+ | var default_src = mainimg.src; | ||
+ | var restore_mainimg = function() { | ||
+ | mainimg.src = default_src; | ||
+ | }; | ||
+ | $(document.getElementById("area_target")).hover(function() { | ||
+ | mainimg.src = "/wiki/images/1/1d/Main_graphic2_target.png"; | ||
+ | }, restore_mainimg); | ||
+ | $(document.getElementById("area_secretion")).hover(function() { | ||
+ | mainimg.src = "/wiki/images/2/23/Main_graphic2_secretion.png"; | ||
+ | }, restore_mainimg); | ||
+ | $(document.getElementById("area_display")).hover(function() { | ||
+ | mainimg.src = "/wiki/images/a/aa/Main_graphic2_display.png"; | ||
+ | }, restore_mainimg); | ||
+ | $(document.getElementById("area_release")).hover(function() { | ||
+ | mainimg.src = "/wiki/images/e/ed/Main_graphic2_release.png"; | ||
+ | }, restore_mainimg); | ||
+ | }); | ||
+ | </script> | ||
+ | </html> | ||
+ | <!---------------------------------------PAGE CONTENT GOES BELOW THIS----------------------------------------> | ||
+ | |||
+ | |||
<html xmlns:v="urn:schemas-microsoft-com:vml" | <html xmlns:v="urn:schemas-microsoft-com:vml" | ||
xmlns:o="urn:schemas-microsoft-com:office:office" | xmlns:o="urn:schemas-microsoft-com:office:office" | ||
Line 21: | Line 49: | ||
{mso-displayed-decimal-separator:"\."; | {mso-displayed-decimal-separator:"\."; | ||
mso-displayed-thousand-separator:"\,";} | mso-displayed-thousand-separator:"\,";} | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
.font513667 | .font513667 | ||
{color:black; | {color:black; | ||
Line 36: | Line 56: | ||
text-decoration:none; | text-decoration:none; | ||
font-family:Tahoma, sans-serif; | font-family:Tahoma, sans-serif; | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
mso-font-charset:0;} | mso-font-charset:0;} | ||
.xl6413667 | .xl6413667 | ||
Line 180: | Line 192: | ||
font-style:normal'>Mutant Data Table</h1> | font-style:normal'>Mutant Data Table</h1> | ||
- | <table border=0 cellpadding=0 cellspacing=0 width= | + | <table border=0 cellpadding=0 cellspacing=0 width=805 class=xl6413667 |
- | style='border-collapse:collapse;table-layout:fixed;width: | + | style='border-collapse:collapse;table-layout:fixed;width:604pt'> |
<col class=xl6413667 width=172 style='mso-width-source:userset;mso-width-alt: | <col class=xl6413667 width=172 style='mso-width-source:userset;mso-width-alt: | ||
6290;width:129pt'> | 6290;width:129pt'> | ||
- | |||
- | |||
<col class=xl6413667 width=297 style='mso-width-source:userset;mso-width-alt: | <col class=xl6413667 width=297 style='mso-width-source:userset;mso-width-alt: | ||
10861;width:223pt'> | 10861;width:223pt'> | ||
Line 193: | Line 203: | ||
<td height=26 class=xl7013667 width=172 style='height:20.1pt;width:129pt'>Mutant | <td height=26 class=xl7013667 width=172 style='height:20.1pt;width:129pt'>Mutant | ||
Name</td> | Name</td> | ||
- | |||
<td class=xl7013667 width=297 style='width:223pt'>Features and Mutations</td> | <td class=xl7013667 width=297 style='width:223pt'>Features and Mutations</td> | ||
<td class=xl6613667 width=168 style='width:126pt'>Transpeptidation per DCP</td> | <td class=xl6613667 width=168 style='width:126pt'>Transpeptidation per DCP</td> | ||
Line 200: | Line 209: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>CapD</td> | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>CapD</td> | ||
- | |||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>No Signal Sequence, Triple | <td class=xl6513667 width=297 style='width:223pt'>No Signal Sequence, Triple | ||
band on protein agarose gel</td> | band on protein agarose gel</td> | ||
Line 211: | Line 216: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CP</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CP</td> | ||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Foldit created linker, | <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker, | ||
Circular Permutation, No Signal Sequence, Single band on protein agarose gel</td> | Circular Permutation, No Signal Sequence, Single band on protein agarose gel</td> | ||
Line 220: | Line 223: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CPNFDelta</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>CapD_CPNFDelta</td> | ||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Foldit created linker, | <td class=xl6513667 width=297 style='width:223pt'>Foldit created linker, | ||
Circular Permutation, No Signal Sequence, Single band on protein agarose gel, | Circular Permutation, No Signal Sequence, Single band on protein agarose gel, | ||
Line 230: | Line 231: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular | 24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular | ||
Line 241: | Line 239: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H</td> | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular | 24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular | ||
Line 253: | Line 248: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | ||
L40R, T59D_M61S</td> | L40R, T59D_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine | 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine | ||
Line 267: | Line 259: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | ||
L40R, T59N_M61S</td> | L40R, T59N_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine | 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine | ||
Line 281: | Line 270: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | ||
L40R, T59S_M61S</td> | L40R, T59S_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to | 24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to | ||
Line 295: | Line 281: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H, | ||
R356K</td> | R356K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine, | 24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine, | ||
Line 308: | Line 291: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24H, | ||
T59R</td> | T59R</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine, | 24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine, | ||
Line 320: | Line 300: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,T59N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24H,T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to | 24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to | ||
Line 332: | Line 309: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24W</td> | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24W</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, | 24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, | ||
Line 343: | Line 317: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular | 24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular | ||
Line 355: | Line 326: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y, | ||
L40R</td> | L40R</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine, | 24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine, | ||
Line 368: | Line 336: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F24Y, | ||
L40R, T59N</td> | L40R, T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to | 24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to | ||
Line 381: | Line 346: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,R305K</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,R305K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine, | 24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine, | ||
Line 393: | Line 355: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to | 24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to | ||
Line 405: | Line 364: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N,R305K</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>F24Y,T59N,R305K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to | 24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to | ||
Line 417: | Line 373: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F60W</td> | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>F60W</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, | 60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, | ||
Line 428: | Line 381: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>G79A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>G79A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular | 79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular | ||
Line 439: | Line 389: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83T</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83T</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular | 83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular | ||
Line 450: | Line 397: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83V</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>I83V</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular | 83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular | ||
Line 461: | Line 405: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular | 40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular | ||
Line 472: | Line 413: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40R</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40R</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular | 40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular | ||
Line 483: | Line 421: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular | 40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular | ||
Line 494: | Line 429: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40W</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>L40W</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular | 40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular | ||
Line 505: | Line 437: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61H</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular | 61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular | ||
Line 516: | Line 445: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular | 61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular | ||
Line 527: | Line 453: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular | 61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular | ||
Line 538: | Line 461: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23K</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular | 23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular | ||
Line 549: | Line 469: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23Q</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>N23Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular | 23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular | ||
Line 560: | Line 477: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S143K</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S143K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular | 143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular | ||
Line 572: | Line 486: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22I, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22I, | ||
T59A</td> | T59A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine, | 22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine, | ||
Line 585: | Line 496: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22Q, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S22Q, | ||
T59Q</td> | T59Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine, | 22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine, | ||
Line 598: | Line 506: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S57H, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>S57H, | ||
M61H</td> | M61H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine, | 57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine, | ||
Line 611: | Line 516: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18L, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18L, | ||
T59Q, M61N, F452W</td> | T59Q, M61N, F452W</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to | 18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to | ||
Line 624: | Line 526: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18S_T20S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T18S_T20S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,<span | 18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine,<span | ||
Line 636: | Line 535: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular | 20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular | ||
Line 647: | Line 543: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20C</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20C</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular | 20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular | ||
Line 658: | Line 551: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular | 20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular | ||
Line 670: | Line 560: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40D</td> | L40D</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine, | ||
Line 683: | Line 570: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40E</td> | L40E</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid, | ||
Line 696: | Line 580: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40F</td> | L40F</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine, | ||
Line 709: | Line 590: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40H</td> | L40H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine, | ||
Line 722: | Line 600: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40K</td> | L40K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine, | ||
Line 735: | Line 610: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40Q</td> | L40Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine, | ||
Line 748: | Line 620: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R</td> | L40R</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine, | 20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine, | ||
Line 761: | Line 630: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, F60E</td> | L40R, F60E</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | ||
Line 774: | Line 640: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, F60Q</td> | L40R, F60Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | ||
Line 787: | Line 650: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, N81E</td> | L40R, N81E</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and | ||
Line 800: | Line 660: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, N81Q</td> | L40R, N81Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and | 20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and | ||
Line 813: | Line 670: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, T59K</td> | L40R, T59K</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and | 20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and | ||
Line 826: | Line 680: | ||
<td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6713667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
L40R, T59K_M61S</td> | L40R, T59K_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine, | 20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine, | ||
Line 840: | Line 691: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S, | ||
T59Q, M61T</td> | T59Q, M61T</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine, | 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine, | ||
Line 852: | Line 700: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine, | ||
Line 864: | Line 709: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61C</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61C</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine, | ||
Line 876: | Line 718: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61D</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61D</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid, | ||
Line 888: | Line 727: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61G</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61G</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine, | ||
Line 900: | Line 736: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61L</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61L</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine, | ||
Line 912: | Line 745: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine, | ||
Line 924: | Line 754: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine, | ||
Line 936: | Line 763: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61T</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61T</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine, | ||
Line 948: | Line 772: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61V</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,M61V</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine, | 20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine, | ||
Line 960: | Line 781: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine, | 20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine, | ||
Line 972: | Line 790: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59S_M61S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S,T59S_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and | 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and | ||
Line 984: | Line 799: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24H</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine, | 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine, | ||
Line 996: | Line 808: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine, | 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine, | ||
Line 1,008: | Line 817: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y,T59N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T20S_F24Y,T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine, | 20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine, | ||
Line 1,020: | Line 826: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | ||
on CapDCP from Threonine to Alanine. Foldit-created linker, Circular | on CapDCP from Threonine to Alanine. Foldit-created linker, Circular | ||
Line 1,031: | Line 834: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2C</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2C</td> | ||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | ||
on CapDCP from Threonine to Cystine. Foldit-created linker, Circular | on CapDCP from Threonine to Cystine. Foldit-created linker, Circular | ||
Line 1,041: | Line 842: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | ||
on CapDCP from Threonine to Serine. Foldit-created linker, Circular | on CapDCP from Threonine to Serine. Foldit-created linker, Circular | ||
Line 1,052: | Line 850: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and | 2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and | ||
Line 1,064: | Line 859: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S,T59S_M61S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T18S_T20S,T59S_M61S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to | 2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to | ||
Line 1,077: | Line 869: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T20S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2S,T20S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine, | 2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine, | ||
Line 1,089: | Line 878: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2V</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T2V</td> | ||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue 2 | ||
on CapDCP from Threonine to Valine. Foldit-created linker, Circular | on CapDCP from Threonine to Valine. Foldit-created linker, Circular | ||
Line 1,099: | Line 886: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61A</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61A</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine, | 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine, | ||
Line 1,111: | Line 895: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61T</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59H_M61T</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine, | 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine, | ||
Line 1,123: | Line 904: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59M</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59M</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular | 59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular | ||
Line 1,134: | Line 912: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59N</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59N</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular | 59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular | ||
Line 1,145: | Line 920: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular | 59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular | ||
Line 1,157: | Line 929: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59Q, | ||
M61Q, F452W</td> | M61Q, F452W</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to | 59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to | ||
Line 1,170: | Line 939: | ||
<tr height=93 style='mso-height-source:userset;height:69.95pt'> | <tr height=93 style='mso-height-source:userset;height:69.95pt'> | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S</td> | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residue | ||
59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular | 59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular | ||
Line 1,182: | Line 948: | ||
<td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S, | <td height=93 class=xl6613667 width=172 style='height:69.95pt;width:129pt'>T59S, | ||
M61H</td> | M61H</td> | ||
- | |||
- | |||
- | |||
<td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | <td class=xl6513667 width=297 style='width:223pt'>Point mutation at residues | ||
59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine, | 59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine, | ||
Line 1,195: | Line 958: | ||
<tr height=0 style='display:none'> | <tr height=0 style='display:none'> | ||
<td width=172 style='width:129pt'></td> | <td width=172 style='width:129pt'></td> | ||
- | |||
<td width=297 style='width:223pt'></td> | <td width=297 style='width:223pt'></td> | ||
<td width=168 style='width:126pt'></td> | <td width=168 style='width:126pt'></td> | ||
Line 1,212: | Line 974: | ||
</html> | </html> | ||
+ | <!---------------------------------------PAGE CONTENT GOES ABOVE THIS----------------------------------------> | ||
+ | |||
+ | <div style="text-align:center"> | ||
+ | '''← [[Team:Washington/Gram_Positive/Test|Back to Testing the Gram(+) Therapeutic]]''' | ||
+ | | ||
+ | </div> |
Latest revision as of 20:37, 25 October 2010
Mutant Data Table
Mutant Name | Features and Mutations | Transpeptidation per DCP | Hydrolysis per DCP |
CapD | No Signal Sequence, Triple band on protein agarose gel | 0.491 | 0.713 |
CapD_CP | Foldit created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 1.000 | 1.000 |
CapD_CPNFDelta | Foldit created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel, Removed "floppy" section to compact protein | 1.035 | 0.878 |
F24A | Point mutation at residue 24 on CapDCP from Phenylalanine to Alanine, Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.021 | 0.061 |
F24H | Point mutation at residue 24 on CapDCP from Phenylalanine to Histidine, Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.108 | 1.205 |
F24H, L40R, T59D_M61S | Point mutation at residues 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Asparagine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.001 | 0.006 |
F24H, L40R, T59N_M61S | Point mutation at residues 24, 40, 59, and 61 on Foldit design from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Aspartic Acid, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.058 | 1.050 |
F24H, L40R, T59S_M61S | Point mutation at residues 24, 40, 59, and 61 on CapDCP from Phenylalanine to Histidine, Leucine to Arginine, Threonine to Serine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.007 |
F24H, R356K | Point mutation at residues 24 and 356 on CapDCP from Phenylalanine to Histidine and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.129 | 0.257 |
F24H, T59R | Point mutation at residues 24 and 59 on CapDCPfrom Phenylalanine to Histidine and Threonine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.011 | 0.005 |
F24H,T59N | Point mutation at residues 24 and 59 on CapDCP from Phenylalanine to Histidine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.007 | 0.029 |
F24W | Point mutation at residue 24 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.006 | 0.044 |
F24Y | Point mutation at residue 24 on CapDCP from Phenylalanine to Tyrosine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.593 | 0.887 |
F24Y, L40R | Point mutation at residues 24 and 40 on CapDCP from Phenylalanine to Tyrosine and Leucine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.009 | -0.013 |
F24Y, L40R, T59N | Point mutation at residues 24, 40, 59 on CapDCP from Phenylalanine to Tyrosine, Leucine to Arginine, and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.003 | 0.157 |
F24Y,R305K | Point mutation at residues 24 and 305 on CapDCP from Phenylalanine to Tyrosine and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.002 | 0.233 |
F24Y,T59N | Point mutation at residues 24 and 59 on CapDCP from Phenylalanine to Tyrosine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.008 | 0.165 |
F24Y,T59N,R305K | Point mutation at residues 24, 59, and 356 on CapDCP from Phenylalanine to Tyrosine, Threonine to Asparagine, and Arginine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.002 | 0.127 |
F60W | Point mutation at residue 60 on CapDCP from Phenylalanine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.239 | 0.489 |
G79A | Point mutation at residue 79 on CapDCP from Glycine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.040 | -0.511 |
I83T | Point mutation at residue 83 on CapDCP from Isoleucine to Threonine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.009 | 0.006 |
I83V | Point mutation at residue 83 on CapDCP from Isoleucine to Valine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.003 | 0.043 |
L40A | Point mutation at residue 40 on CapDCP from Leucine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.150 | 0.413 |
L40R | Point mutation at residue 40 on CapDCP from Leucine to Arginine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 1.157 | 1.527 |
L40S | Point mutation at residue 40 on CapDCP from Leucine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.166 | 0.577 |
L40W | Point mutation at residue 40 on CapDCP from Leucine to Tryptophan. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.825 | 1.215 |
M61H | Point mutation at residue 61 on CapDCP from Methionine to Histidine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | -0.003 | 0.002 |
M61N | Point mutation at residue 61 on CapDCP from Methionine to Asparagine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.011 | 0.002 |
M61S | Point mutation at residue 61 on CapDCP from Methionine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.262 | 0.485 |
N23K | Point mutation at residue 23 on CapDCP from Asparagine to Lysine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.818 | 0.839 |
N23Q | Point mutation at residue 23 on CapDCP from Asparagine to Glutamine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.165 | 0.646 |
S143K | Point mutation at residue 143 on CapDCP from Serine to Lysine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.574 | 0.426 |
S22I, T59A | Point mutation at residues 22 and 59 on CapDCP from Serine to Isoleucine and Threonine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.030 | -0.057 |
S22Q, T59Q | Point mutation at residues 22 and 59 on CapDCP from Serine to Glutamine and Threonine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | -0.012 | 0.085 |
S57H, M61H | Point mutation at residues 57 and 61 on CapDCP from Serine to Histidine and Methionine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | -0.004 | -0.007 |
T18L, T59Q, M61N, F452W | Point mutation at residues 18, 59, 61, and 452 on CapDCP from Threonine to Leucine, Threonine to Glutamine, Methionine to Asparagine, and Phenylalanine to Tryptophan, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.020 | -0.028 |
T18S_T20S | Point mutation at residues 18 and 20 on CapDCP from Threonine to Serine and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.617 | 1.186 |
T20A | Point mutation at residue 20 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.011 | 0.021 |
T20C | Point mutation at residue 20 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.090 | 0.142 |
T20S | Point mutation at residue 20 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.639 | 1.443 |
T20S, L40D | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.853 | 0.001 |
T20S, L40E | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.163 | 0.637 |
T20S, L40F | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Phenylalanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.246 | 0.335 |
T20S, L40H | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.001 | 0.012 |
T20S, L40K | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.007 |
T20S, L40Q | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.126 | 0.478 |
T20S, L40R | Point mutation at residues 20 and 40 on CapDCP from Threonine to Serine and Leucine to Arginine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.009 |
T20S, L40R, F60E | Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.048 | 0.028 |
T20S, L40R, F60Q | Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.002 | 0.007 |
T20S, L40R, N81E | Point mutation at residues 20, 40, and 60 on CapDCP from Threonine to Serine, Leucine to Arginine, and Phenylalanine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.001 | -0.004 |
T20S, L40R, N81Q | Point mutation at residues 20, 40, and 81 on CapDCP from Threonine to Serine, Leucine to Arginine, and Asparagine to Glutamine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.422 | 0.321 |
T20S, L40R, T59K | Point mutation at residues 20, 40, and 59 on CapDCP from Threonine to Serine, Leucine to Arginine, and Threonine to Lysine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.048 | 0.033 |
T20S, L40R, T59K_M61S | Point mutation at residues 20, 40, 59, and 61 on CapDCP from Threonine to Serine, Leucine to Arginine, Threonine to Lysine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.010 | 0.032 |
T20S, T59Q, M61T | Point mutation at residues 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Glutamine, and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.007 | -0.069 |
T20S,M61A | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.005 | 0.045 |
T20S,M61C | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Cystine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.102 | 0.207 |
T20S,M61D | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Aspartic Acid, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.004 | 0.003 |
T20S,M61G | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Glycine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.004 | 0.029 |
T20S,M61L | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Leucine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.004 | 0.029 |
T20S,M61N | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.003 | 0.002 |
T20S,M61S | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.007 | 0.053 |
T20S,M61T | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.038 | 0.363 |
T20S,M61V | Point mutation at residues 20 and 61 on CapDCP from Threonine to Serine and Methionine to Valine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.004 | 0.039 |
T20S,T59N | Point mutation at residues 20 and 59 on CapDCP from Threonine to Serine and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.019 | 0.125 |
T20S,T59S_M61S | Point mutation at residues 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, and Methionine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.300 | 0.719 |
T20S_F24H | Point mutation at residues 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.008 | 0.097 |
T20S_F24Y | Point mutation at residues 20 and 24 on CapDCP from Threonine to Serine and Phenylalanine to Tyrosine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.040 | 0.201 |
T20S_F24Y,T59N | Point mutation at residues 20, 24, and 59 on CapDCP from Threonine to Serine, Phenylalanine to Tyrosine, and Threonine to Asparagine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.013 | 0.048 |
T2A | Point mutation at residue 2 on CapDCP from Threonine to Alanine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.007 | -0.020 |
T2C | Point mutation at residue 2 on CapDCP from Threonine to Cystine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.001 | -0.005 |
T2S | Point mutation at residue 2 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.024 | 0.325 |
T2S,T18S_T20S | Point mutation at residues 2, 18, and 20 on CapDCP from Threonine to Serine, Threonine to Serine, and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.144 | 0.250 |
T2S,T18S_T20S,T59S_M61S | Point mutation at residues 2, 18, 20, 59, and 61 on CapDCP from Threonine to Serine, Threonine to Serine, Threonine to Serine, Threonine to Serine and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.003 | 0.022 |
T2S,T20S | Point mutation at residues 2 and 20 on CapDCP from Threonine to Serine and Threonine to Serine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.106 | 0.089 |
T2V | Point mutation at residue 2 on CapDCP from Threonine to Valine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.000 |
T59H_M61A | Point mutation at residues 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Alanine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.000 |
T59H_M61T | Point mutation at residues 59 and 61 on CapDCP from Threonine to Histidine and Methionine to Threonine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.000 |
T59M | Point mutation at residue 59 on CapDCP from Threonine to Methionine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.008 | 0.008 |
T59N | Point mutation at residue 59 on CapDCP from Threonine to Asparagine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.232 | 0.868 |
T59Q | Point mutation at residue 59 on CapDCP from Threonine to Glutamine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.000 | 0.000 |
T59Q, M61Q, F452W | Point mutation at residues 59, 61, and 452 on CapDCP from Threonine to Glutamine, Threonine to Glutamine, and Phenylalanine to Tryptophan, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | -0.014 | 0.037 |
T59S | Point mutation at residue 59 on CapDCP from Threonine to Serine. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 3.525 | 1.047 |
T59S, M61H | Point mutation at residues 59 and 61 on CapDCP from Threonine to Serine and Methionine to Histidine, respectively. Foldit-created linker, Circular Permutation, No Signal Sequence, Single band on protein agarose gel | 0.013 | 0.051 |